SG Americas Securities LLC decreased its position in shares of Simulations Plus, Inc. (NASDAQ:SLP – Free Report) by 4.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 25,969 shares of the technology company’s stock after selling 1,173 shares during the quarter. SG Americas Securities LLC owned 0.13% of Simulations Plus worth $832,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of SLP. EntryPoint Capital LLC bought a new stake in Simulations Plus during the first quarter worth about $57,000. Allspring Global Investments Holdings LLC acquired a new position in Simulations Plus during the first quarter worth about $70,000. Connecticut Wealth Management LLC acquired a new position in Simulations Plus during the first quarter worth about $204,000. Los Angeles Capital Management LLC acquired a new position in Simulations Plus during the second quarter worth about $206,000. Finally, Janney Montgomery Scott LLC acquired a new position in shares of Simulations Plus in the first quarter valued at approximately $208,000. Institutional investors own 78.08% of the company’s stock.
Insider Buying and Selling
In related news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $31.26, for a total value of $625,200.00. Following the transaction, the director now directly owns 3,481,592 shares in the company, valued at $108,834,565.92. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders have sold a total of 60,750 shares of company stock worth $2,145,055 in the last ninety days. Corporate insiders own 20.90% of the company’s stock.
Simulations Plus Stock Performance
Analyst Ratings Changes
Several research analysts have recently issued reports on the company. KeyCorp assumed coverage on Simulations Plus in a research note on Monday, July 29th. They issued an “overweight” rating and a $47.00 price objective for the company. William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a research note on Thursday, September 12th. Craig Hallum reaffirmed a “buy” rating and issued a $56.00 price objective on shares of Simulations Plus in a research note on Wednesday, July 3rd. Finally, JMP Securities assumed coverage on Simulations Plus in a research note on Tuesday, July 16th. They issued a “market perform” rating for the company. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, Simulations Plus has an average rating of “Moderate Buy” and a consensus target price of $56.00.
Check Out Our Latest Report on SLP
Simulations Plus Profile
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Further Reading
- Five stocks we like better than Simulations Plus
- What is a Bond Market Holiday? How to Invest and Trade
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- Why Are Stock Sectors Important to Successful Investing?
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- Stock Analyst Ratings and Canadian Analyst Ratings
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.